From the Journals
The findings “could transform the HIV prevention landscape for so many people,” said Megan Coleman, DNP.
A troubling link between the top HIV drug dolutegravir and neural tube defects, first reported in 2018, now seems much less dangerous.
The 35-year-old Brazilian man participated in a trial in which he received an intensified antiretroviral regimen plus supplemental vitamin B3...
News from the FDA/CDC
“The availability of new classes of antiretroviral drugs is critical for heavily treatment-experienced patients living with multidrug resistant...
“We don’t see any signs that people with HIV should take extra precautions” to protect themselves from COVID-19, said Keith Sigel, MD.
Patients are making calculations about managing physical distancing using their own internal formulas, said Dr. Jack Drescher.
One of the biggest wins for ID dermatology over the last 5 decades has been herpes. It started with the approval of acyclovir in 1981.